Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Sereflo
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sereflo 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BIABBG
|
Sereflo | Fluticasone propionate (Inhalation) | Respiratory System | 31,375 |
|
Sereflo 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BIAABF
|
Sereflo | Fluticasone propionate (Inhalation) | Respiratory System | 29,844 |
|
Sereflo Ciphaler 50microg / 250microg/dose dry pdr inh
0302000N0BIACAY
|
Sereflo | Fluticasone propionate (Inhalation) | Respiratory System | 675 |
|
Sereflo Ciphaler 50microg / 500microg/dose dry pdr inh
0302000N0BIADAZ
|
Sereflo | Fluticasone propionate (Inhalation) | Respiratory System | 496 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.